Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health. In: Center for Behavioral Health Statistics and Quality SAa, Administration MHS, editors. 2022.

Esser MB, Sherk A, Liu Y, Naimi TS, Stockwell T, Stahre M, et al. Deaths and Years of Potential Life Lost From Excessive Alcohol Use - United States, 2011–2015. MMWR Morb Mortal Wkly Rep. 2020;69(39):1428–33.

Article  Google Scholar 

Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 2013;35(2):155–73.

Google Scholar 

Im GY. Acute Alcoholic Hepatitis. Clin Liver Dis. 2019;23(1):81–98.

Article  Google Scholar 

Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58(3):593–608.

Article  Google Scholar 

Younossi ZM, Wong G, Anstee QM, Henry L. The Global Burden of Liver Disease. Clin Gastroenterol Hepatol. 2023;21(8):1978–91.

Article  Google Scholar 

Osna NA, Donohue TM Jr, Kharbanda KK. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017;38(2):147–61.

Google Scholar 

Bataller R, Arab JP, Shah VH. Alcohol-Associated Hepatitis. N Engl J Med. 2022;387(26):2436–48.

Article  Google Scholar 

Stickel F, Hampe J. Genetic determinants of alcoholic liver disease. Gut. 2012;61(1):150–9.

Article  Google Scholar 

Wang Q, Chang B, Li X, Zou Z. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. Journal of clinical and translational hepatology. 2021;9(1):90–8.

Google Scholar 

Lu Y, Cederbaum AI. Cytochrome P450s and Alcoholic Liver Disease. Curr Pharm Des. 2018;24(14):1502–17.

Article  Google Scholar 

Sun J, Fu J, Li L, Chen C, Wang H, Hou Y, et al. Nrf2 in alcoholic liver disease. Toxicol Appl Pharmacol. 2018;357:62–9.

Article  Google Scholar 

Schwantes-An TH, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, et al. Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors. Hepatology. 2021;73(5):1920–31.

Article  Google Scholar 

Dolganiuc A, Szabo G. In vitro and in vivo models of acute alcohol exposure. World J Gastroenterol. 2009;15(10):1168–77.

Article  Google Scholar 

Eysseric H, Gonthier B, Soubeyran A, Bessard G, Saxod R, Barret L. There is not simple method to maintain a constant ethanol concentration in long-term cell culture: keys to a solution applied to the survey of astrocytic ethanol absorption. Alcohol (Fayetteville, NY). 1997;14(2):111–5.

Article  Google Scholar 

Nath V, Reneau JC, Dertien JS, Agrawal RG, Guerra I, Bhakta Y, et al. An in vitro model for studying the effects of continuous ethanol exposure on N-methyl-D-aspartate receptor function. Alcohol. 2012;46(1):3–16.

Article  Google Scholar 

Kim W, Jeong HS, Kim SC, Choi CH, Lee KH. Chronic Alcohol Exposure of Cells Using Controlled Alcohol-Releasing Capillaries. Cells. 2021;10(5):1120.

Article  Google Scholar 

Jensen KP, Lieberman R, Kranzler HR, Gelernter J, Clinton K, Covault J. Alcohol-responsive genes identified in human iPSC-derived neural cultures. Transl Psychiatry. 2019;9(1):96.

Article  Google Scholar 

Adams C, Conigrave JH, Lewohl J, Haber P, Morley KC. Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis. Brain Behav Immun. 2020;89:501–12.

Article  Google Scholar 

Liu G, Zhang Y, Liu C, Xu D, Zhang R, Cheng Y, et al. Luteolin Alleviates Alcoholic Liver Disease Induced by Chronic and Binge Ethanol Feeding in Mice. The Journal of Nutrition. 2014;144(7):1009–15.

Article  Google Scholar 

Yao G, Tang X, Ye Z, Yan W, Yu J, Wu Y, et al. Protective effect of Camellia vietnamensis active peptide on alcohol-induced hepatocyte injury. Food Agricult Immunol. 2021;32(1):425–49.

Article  Google Scholar 

Hisai H, Kato J, Kobune M, Murakami T, Miyanishi K, Takahashi M, et al. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res. 2003;9(13):4852–9.

Google Scholar 

Sheng J, Xu Z. Three decades of research on angiogenin: a review and perspective. Acta Biochimica et Biophysica Sinica. 2015;48(5):399–410.

Article  Google Scholar 

Broughton SE, Hercus TR, Nero TL, Kan WL, Barry EF, Dottore M, et al. A dual role for the N-terminal domain of the IL-3 receptor in cell signalling. Nat Comm. 2018;9(1):386.

Article  Google Scholar 

Pridans C, Sauter KA, Irvine KM, Davis GM, Lefevre L, Raper A, et al. Macrophage colony-stimulating factor increases hepatic macrophage content, liver growth, and lipid accumulation in neonatal rats. Am J Physiol Gastrointest Liver Physiol. 2018;314(3):G388–98.

Article  Google Scholar 

Ma W, Wang ZR, Shi L, Yuan Y. Expression of macrophage inflammatory protein-1alpha in Kupffer cells following liver ischemia or reperfusion injury in rats. World J Gastroenterol. 2006;12(24):3854–8.

Article  Google Scholar 

Yang X, Shao C, Duan L, Hou X, Huang Y, Gao L, et al. Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α. Cancer Letters. 2021;517:46–54.

Article  Google Scholar 

Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol. 2001;13(7):791–801.

Article  Google Scholar 

Liu Z, Zhang G, Chen J, Tong J, Wang H, Chen J, et al. G-CSF promotes the viability and angiogenesis of injured liver via direct effects on the liver cells. Molecul Biol Rep. 2022;49(9):8715–25.

Article  Google Scholar 

Barsheshet Y, Wildbaum G, Levy E, Vitenshtein A, Akinseye C, Griggs J, et al. CCR8(+)FOXp3(+) T(reg) cells as master drivers of immune regulation. Proc Natl Acad Sci U S A. 2017;114(23):6086–91.

Article  Google Scholar 

Sahin H, Borkham-Kamphorst E, Kuppe C, Zaldivar MM, Grouls C, Al-samman M, et al. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice. Hepatology. 2012;55(5):1610–9.

Article  Google Scholar 

Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, Tacke F. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One. 2011;6(6):e21381.

Article  Google Scholar 

Martínez-Uña M, López-Mancheño Y, Diéguez C, Fernández-Rojo MA, Novelle MG. Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. Int J Mol Sci. 2020;21(24):9368.

Article  Google Scholar 

Ying HZ, Chen Q, Zhang WY, Zhang HH, Ma Y, Zhang SZ, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review). Mol Med Rep. 2017;16(6):7879–89.

Article  Google Scholar 

Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest. 1994;94(4):1563–9.

Article  Google Scholar 

Liepelt A, Tacke F. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases. Am J Physiol Gastrointest Liver Physiol. 2016;311(2):G203-9.

Article  Google Scholar 

Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4*. Journal of Biological Chemistry. 1997;272(23):15036–42.

Article  Google Scholar 

Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest. 1998;102(11):1933–41.

Article  Google Scholar 

Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and Fibrogenesis in Chronic Liver Diseases. Cell Mol Gastroenterol Hepatol. 2015;1(5):477–88.

Article  Google Scholar 

Shen H, Yu H, Li QY, Wei YT, Fu J, Dong H, et al. Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells. Acta Pharmacol Sin. 2022;43(11):2917–28.

Article  Google Scholar 

Orlandi P, Solini A, Banchi M, Brunetto MR, Cioni D, Ghiadoni L, Bocci G. Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach. Pharmaceuticals. 2021;14(10):995.

Article  Google Scholar 

Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367–79.

Article  Google Scholar 

Gao B, Li S, Tan Z, Ma L, Liu J. ACTG1 and TLR3 are biomarkers for alcohol-associated hepatocellular carcinoma. Oncol Lett. 2019;17(2):1714–22.

Google Scholar 

Zhang X, Kang C, Li N, Liu X, Zhang J, Gao F, Dai L. Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis. PeerJ. 2019;7:e6375.

Article  Google Scholar 

Yu JH, Song SJ, Kim A, Choi Y, Seok JW, Kim HJ, et al. Suppression of PPARgamma-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis. Sci Rep. 2016;6:29352.

Article  Google Scholar 

Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology. 2011;54(6):2185–97.

Article  Google Scholar 

Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, et al. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun. 2019;10(1):3126.

Article  Google Scholar 

Spencer MR, Curtin SC, Garnett MF. Alcohol-induced Death Rates in the United States, 2019–2020. NCHS Data Brief. 2022;448:1–8.

Google Scholar 

Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, et al. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019;114(10):1574–86.

Article  Google Scholar